|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Licensing revenue – Related Party | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Change in fair value of contingent consideration | |||||
| Impairment of long-lived assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on warrant liability | |||||
| Other expense, net | |||||
| Net loss | |||||
| Unrealized gain (loss) on marketable debt securities | |||||
| Other comprehensive gain (loss) | |||||
| Unrealized gain (loss) on marketable debt securities | |||||
| Comprehensive loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted average number of shares used in computing net loss per share, basic | |||||
| Weighted average number of shares used in computing net loss per share, diluted | |||||
Loading...
